Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-14 Option Award | 2026-08-18 4:03 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer & EVP | 43,086 | $0 | 123,448 (Direct) | View |
| 2026-08-14 Exercise | 2026-08-18 4:03 pm | N/A 2027-12-31 | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer & EVP | 5,233 | $0 | 123,448 (Direct) | View |
| 2026-08-14 Tax Withholding | 2026-08-18 4:03 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer & EVP | 2,662 | $26.18 | 123,448 (Direct) | View |
| 2026-06-25 Tax Withholding | 2026-08-04 4:30 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer & EVP | 6,480 | $31.21 | 64,251 (Direct) | View |
| 2026-06-25 Exercise | 2026-08-04 4:30 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer & EVP | 34,742 | $0 | 64,251 (Direct) | View |
| 2026-07-31 Tax Withholding | 2026-08-04 4:30 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Chief Financial Officer & EVP | 10,576 | $24.36 | 64,251 (Direct) | View |
| 2026-07-01 Option Award | 2026-07-02 5:00 pm | N/A 2036-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 125,000 | $0 | 125,000 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-19 4:01 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Interim Co-CEO and CFO | 15,699 | $0 | 44,818 (Direct) | View |
| 2026-05-15 Exercise | 2026-05-19 4:01 pm | N/A 2027-12-31 | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Interim Co-CEO and CFO | 15,699 | $0 | 44,818 (Direct) | View |
| 2026-05-15 Tax Withholding | 2026-05-19 4:01 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Interim Co-CEO and CFO | 5,632 | $32.07 | 44,818 (Direct) | View |
| 2026-03-13 Option Award | 2026-03-16 5:00 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Interim Co-CEO and CFO | 39,809 | $0 | 39,809 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 5:28 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Interim Co-CEO and CFO | 20,787 | $0 | 20,787 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-02 9:00 pm | N/A 2035-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 6:31 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J CFO | 41,867 | $0 | 41,867 (Direct) | View |
Ownership | 2025-03-18 6:02 pm | N/A N/A | STAAR SURGICAL CO | STAA | ANDREWS DEBORAH J Interim CFO | 0 | $0 | 8,586 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:00 pm | N/A 2034-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-07-01 Option Award | 2023-07-03 5:46 pm | N/A 2033-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:15 pm | N/A 2032-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 50,000 | $0 | 50,000 (Direct) | View |